PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2000 December; 1(4): 17–25.
Published online 2000 August 28. doi:  10.1208/pt010428
PMCID: PMC2750452

Formulation and in vitro transfection efficiency of poly (D, L-lactideco-glycolide) microspheres containing plasmid DNA for gene delivery

Abstract

The stability, in vitro release, and in vitro cell transfection efficiency of plasmid DNA (pDNA) poly (D,L.-lactide-co-glycolide) (PLGA) microsphere formulations were investigated. PLGA microspheres containing free and polylysine (PLL)-complexed pDNA were prepared by a water-oil-water solvent extraction/evaporation technique. Encapsulation enhanced the retention of the supereoiled structure of pDNA as determined by gel electrophoresis. PLL complexation of pDNA prior to encapsulation increased both the stability of the supercoiled form and the encapsulation efficiency. Free pDNA was completely degraded after exposure to DNase while encapsulation protected the pDNA from enzymatic degradation. Rapid initial in vitro release of pDNA was obtained from microspheres containing free pDNA. while the release from microspheres containing PLL-complexed pDNA was sustained for more than 42 days. Bioactivity of encapsulated pDNA determined by in vitro cell transfection using Chinese hamster ovary cells (CHO) showed that the bioactivity of encapsulated pDNA was retained in both formulations but to a greater extent with PLL-complexed pDNA microspheres. These results demonstrated that PLGA microspheres could be used to formulate a controlledrelease delivery system for pDNA that can protect the pDNA from DNase degradation without loss of functional activity.

Key Words: PLGA, Microspheres, Plasmid DNA, Controlled Release

Full Text

The Full Text of this article is available as a PDF (861K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Luo D, Woodrow-Mumford K, Belcheva N, Saltzaman WM. Controlled DNA delivery systems. Pharm. Res. 1999;16:1300–1307. doi: 10.1023/A:1014870102295. [PubMed] [Cross Ref]
2. Crystal RG. Transfer of genes to humans early lessons and obstacles to success. Science. 1995;270:404–410. doi: 10.1126/science.270.5235.404. [PubMed] [Cross Ref]
3. Thieny AR, Rabinovich P, Peng B, Mahan LC, Bryant JL, Gallo RC. Characterization of liposome-mediated gene delivery expression, stability and phamacokinetics of plasmid DNA. Gene Ther. 1997;4:226–237. doi: 10.1038/sj.gt.3300350. [PubMed] [Cross Ref]
4. felgner PL, Ringold GM. Cationic liposome-mediated transfection. Nature. 1989;337:387–388. doi: 10.1038/337387a0. [PubMed] [Cross Ref]
5. Wasan EK, Fairchild A, Bally MB. Cationie liposome-plasmid DNA complexes used of gene transfer retain a significant trapped volume. J of Pharm Sci. 1998;87:5–14. [PubMed]
6. Felgner PL, Tsai YJ, Sukhu L, Wheeler CJ, Manthorpe M, Marshall J, Cheng SH. Improved cationic lipid formulations for in vivo gene therapy. Ann NY Acad Sci. 1995;772:126–139. doi: 10.1111/j.1749-6632.1995.tb44738.x. [PubMed] [Cross Ref]
7. Liu Y, Liggitt D, Zhong W, Tu G, Gaensler K, Debs R. Cationic liposome-mediated intravenous gene delivery. J Biol Chem. 1995;270:24864–24870. doi: 10.1074/jbc.270.42.24864. [PubMed] [Cross Ref]
8. Xu Y, Szoka FC. Mechanism of DNA release from cationieliposome/DNA complexes used in cell transfection. Biochem. 1996;35:5616–5626. doi: 10.1021/bi9602019. [PubMed] [Cross Ref]
9. Niven R, Pearlman R, Wedeking T, et al. Biodistribution of racholabeled lipid-DNA complexes and DNA in mice. J Pharm Sci. 1998;87:1292–1299. doi: 10.1021/js980087a. [PubMed] [Cross Ref]
10. Pouton CW, Lucas P, Thomas BJ, Uduehi AN, Milroy DA, Moss SH. Polycation-DNA complexes for gene delivery: a comparison of the biopharmacentical properties of cationic polypeptides and cationic lipids. J Contr Rel. 1998;53:289–299. doi: 10.1016/S0168-3659(98)00015-7. [PubMed] [Cross Ref]
11. Mumper RJ, Duguid JG, Anwer K, Barron MK, Nitta H, Rolland AP. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery tomuscle. Pharm Res. 1996;13:701–709. doi: 10.1023/A:1016039330870. [PubMed] [Cross Ref]
12. MacDonald RC, Rakhmanova VA, Choi KL, Rosenzweig HS, Lahiri MK. O-ethylphosphatidylcholine: a metabolizable cationic phospholipid which is a serum-compatible DNA transfection agent. J Phann Sci. 1999;88:896–904. doi: 10.1021/js990006q. [PubMed] [Cross Ref]
13. DeLuca PP, Mehta RC, Hausberger AG, Thanoo BC. Biodegradable polyesters for drug and polypeptide delivery. In: El-Nokaly MA, Piatt DM, Charpentier BA, editors. Polymeric drug delivery systems. Washington, DC: American Chemical Society; 1993. pp. 53–79.
14. Mehta RC, Jeyanthi R, Calis S, Thanoo BC, Burton KW, DeLuca PP. Biodegradable microspheres as depot system for parenteral delivery of peptide drugs. J. Cont. Rel. 1994;29:375–384. doi: 10.1016/0168-3659(94)90082-5. [Cross Ref]
15. DeLuca PP. Formulation Strategies for Proteins and Peptides. J. KorPharm Sci. 1993;23:S51–S60.
16. Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. J Cont Rel. 1999;60:279–286. doi: 10.1016/S0168-3659(99)00076-0. [PubMed] [Cross Ref]
17. Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Stability of poly(L-lysine)-complexed plasmid DNA during mechanical stress and DNase I treatment. Pharm Dev Technol. 1999;4:491–498. doi: 10.1081/PDT-100101386. [PubMed] [Cross Ref]
18. Yasuhiko T, Yoshito I. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophages. Biomaterials. 1988;9:356–362. doi: 10.1016/0142-9612(88)90033-6. [PubMed] [Cross Ref]
19. Kanke M, Morlier E, Geissler R, Powell R, Kaplan A, DeLuca PP. Interaction of microspheres with Blood constituents II: Uptake of biodegradable particles by macrophages. J. Parenteral Sci and Tech. 1986;40:114–118. [PubMed]
20. Middaugh CR, Evans RK, Montgomery DL, Casmiro DR. Analysis of Plasmid DNA from a pharmaceutical Perspective. J. Pharm. Sci. 1998;87:130–146. doi: 10.1021/js970367a. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists